Latest Earnings Results: Q3 '26
Estimated EPS
$5.68
Reported EPS
$7.48
Surprise
+31.6%
Estimated Rev
$22.58B
Reported Rev
$24.4B
Surprise
+8.03%
• Reported GAAP EPS of $7.48 up 6.55% YoY • Reported revenue of $24.4B up 38.61% YoY • Lilly raised 2026 revenue guidance to $91B and updated performance margin guidance to 52.0% to 52.5%; full-year non-GAAP EPS guidance is $35.00 to $36.00.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $11.20 | -- | -- | N/A |
Q3 '26 | $5.68 | $7.48 | 31.60% | BEAT |
Q2 '26 | $6.01 | $8.38 | 39.53% | BEAT |
Q1 '26 | $6.97 | $8.55 | 22.71% | BEAT |
Q4 '25 | $6.91 | $7.54 | 9.10% | BEAT |